M-11004 Fully Automated Cervical Cytology Intelligent Screening System

Fully Automated Cervical Cytology Intelligent Screening System
This system accomplishes complete automation in digital slide reading and professional intelligent image recognition for cervical cytology smears. It significantly reduces the false-negative rate in cervical cell screening. The system is capable of automatically processing 200 slides continuously, enabling unattended operations and nighttime automatic processing capabilities. Intelligent image recognition technology identifies abnormal lesion cells and provides risk level alerts while excluding normal cell images, reducing the workload for pathologists by more than 80% in reviewing cytological slides.
 
Usage Scenarios:
Hospitals and Diagnostic Centers: For automated and accurate cervical cytology screening, reducing the workload for pathologists and improving diagnostic accuracy.
Laboratories: For high-throughput cervical cell screening, enabling continuous and unattended operations, especially useful for large-scale screening programs.
Public Health Initiatives: For mass cervical cancer screening programs, enhancing early detection and reducing false-negative rates.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced automation technology is in high demand to improve efficiency and accuracy in medical diagnostics.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are expanding their screening programs and investing in modern medical technologies.
Global Health Programs: International health initiatives focused on improving cervical cancer screening and diagnostics in low-resource settings.